Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
53,512,954,839
-
Total 13F shares
-
174,742
-
Share change
-
+52,987
-
Total reported value
-
$326,347
-
Price per share
-
$1.86
-
Number of holders
-
8
-
Value change
-
+$98,948
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX) as of Q1 2024
As of 31 Mar 2024 Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 174,742 shares of stock of the company.
Largest 8 holders included Omnia Family Wealth, LLC, SABBY MANAGEMENT, LLC, Cerity Partners LLC, RENAISSANCE TECHNOLOGIES LLC, BANK OF AMERICA CORP /DE/, Truvestments Capital LLC, MORGAN STANLEY, and Cornerstone Planning Group LLC.
This table shows 8 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.